The shifting landscape of cancer care points towards a significantly personalized approach. Moving beyond the “one-size-fits-all” model, the future of authentic cancer treatment copyrights on integrating multi-omics data – encompassing genomics, proteomics, and metabolomics – to comprehensively profi